Journal of Clinical Endocrinology & Metabolism, Vol 81, 2247-2249, Copyright © 1996 by Endocrine Society

ARTICLES

Maternal to fetal thyroxine transmission in the human term placenta is limited by inner ring deiodination

RH Mortimer, JP Galligan, GR Cannell, RS Addison and MS Roberts
Conjoint Endocrine Laboratory, Royal Brisbane Hospital, Brisbane, Queensland, Australia.

Placental deiodination of T4 to rT3 has been proposed as the factor controlling materno-fetal transmission of T4. We investigated T4 transfer in the isolated perfused human placental lobule with and without addition of the deiodinase inhibitor, iopanoic acid. T4 (150 nmol/L) in protein-free medium was added to the maternal circuit. Without iopanoic acid, the appearance of T4 in the fetal circuit was very low, with fetal T4 levels reaching only 4.1 +/- 0.84 pmol/L at 6 h. Levels of rT3 rose progressively in both circuits, reaching 28.8 +/- 5.5 nmol/L in the maternal and 12.4 +/- 3.2 nmol/L in the fetal circuit by 6 h. No T3 could be measured in either circuit. Addition of 0.5 nmol/L iopanoic acid to maternal perfusate, however, resulted in significant reduction in the appearance of rT3 [maternal levels, 0.58 +/- 0.06 nmol/L (2% of control values); fetal levels, 0.33 +/- 0.03 nmol/L (2.7% of control values)] and a major (approximately 2700-fold) increase in T4 appearance in the fetal circuit, with fetal T4 levels reaching 10.1 +/- 3.4 nmol/L at 6 h. These results support the hypothesis that placental inner ring (type III) deiodination is a major factor controlling placental transmission of maternal T4.

This article has been cited by other articles:

				K. A. Landers, B. D. McKinnon, H. Li, V. N. Subramaniam, R. H. Mortimer, and K. Richard Carrier-Mediated Thyroid Hormone Transport into Placenta by Placental Transthyretin J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2610 - 2616. [Abstract] [Full Text] [PDF]

				D. L. St. Germain, V. A. Galton, and A. Hernandez Defining the Roles of the Iodothyronine Deiodinases: Current Concepts and Challenges Endocrinology, March 1, 2009; 150(3): 1097 - 1107. [Abstract] [Full Text] [PDF]

				J. Girling Thyroid disease in pregnancy Obstet Gynaecol (Lond), October 1, 2008; 10(4): 237 - 243. [Abstract] [Full Text] [PDF]

				B. McKinnon, H. Li, K. Richard, and R. Mortimer Synthesis of Thyroid Hormone Binding Proteins Transthyretin and Albumin by Human Trophoblast J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6714 - 6720. [Abstract] [Full Text] [PDF]

				D. P. Carvalho Modulation of Uterine Iodothyronine Deiodinases--A Critical Event for Fetal Development? Endocrinology, October 1, 2003; 144(10): 4250 - 4252. [Full Text] [PDF]

				S. Chan, S. Kachilele, E. Hobbs, J. N. Bulmer, K. Boelaert, C. J. McCabe, P. M. Driver, A. R. Bradwell, M. Kester, T. J. Visser, et al. Placental Iodothyronine Deiodinase Expression in Normal and Growth-Restricted Human Pregnancies J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4488 - 4495. [Abstract] [Full Text] [PDF]

				S. A. Huang, D. M. Dorfman, D. R. Genest, D. Salvatore, and P. R. Larsen Type 3 Iodothyronine Deiodinase Is Highly Expressed in the Human Uteroplacental Unit and in Fetal Epithelium J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1384 - 1388. [Abstract] [Full Text] [PDF]

				A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF]

				G. Morreale de Escobar, M. Jesús Obregón, and F. Escobar del Rey Is Neuropsychological Development Related to Maternal Hypothyroidism or to Maternal Hypothyroxinemia? J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 3975 - 3987. [Abstract] [Full Text]

				F. Santini, L. Chiovato, P. Ghirri, P. Lapi, C. Mammoli, L. Montanelli, G. Scartabelli, G. Ceccarini, L. Coccoli, I. J. Chopra, et al. Serum Iodothyronines in the Human Fetus and the Newborn: Evidence for an Important Role of Placenta in Fetal Thyroid Hormone Homeostasis J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 493 - 498. [Abstract] [Full Text]

				R. Bajoria, N. M. Fisk, and S. F. Contractor Liposomal Thyroxine: A Noninvasive Model for Transplacental Fetal Therapy J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3271 - 3277. [Abstract] [Full Text] [PDF]